Table 1 Characteristics of study population

Clinical Characteristics

 Male [n (%)]

49(59.0)

103(59.2)

0.981

 Age, years, median (IQR)

62.23 ± 10.05

61.84 ± 8.74

0.750

 Hypertension, n (%)

53(63.9)

81(46.6)

 < 0.001

 Previous stroke, n (%)

5(6.0)

9(5.2)

0.774

 Diabetes, n (%)

21(25.3)

27(15.5)

0.086

 Current smoking, n (%)

26(31.3)

44(25.3)

0.369

Laboratory Characteristics

 Rapid glucose, mmol/L

7.46 ± 2.70

7.09 ± 2.77

0.311

 HbA1c (%)

6.66 ± 1.18

6.37 ± 0.98

0.040

 TC, mmol/L

4.66 ± 1.13

4.33 ± 1.05

0.022

 TG, mmol/L

2.32 ± 0.70

1.98 ± 1.29

0.079

 HDL-c, mmol/L

1.14 ± 0.31

1.23 ± 0.30

0.040

 LDL-c, mmol/L

2.50 ± 0.84

2.23 ± 0.70

0.007

 Platelet count, 10⁹/L

216.94 ± 63.59

200.07 ± 57.41

0.034

 Neutrophil count, 10⁹/L

4.63 ± 1.65

3.76 ± 1.17

 < 0.001

 Lymphocyte count, 10⁹/L

1.61 ± 0.60

1.45 ± 0.55

0.028

 Monocyte count, 10⁹/L,

0.49 ± 0.15

0.42 ± 0.15

0.001

 Creatinine, mg/dl

78.5 ± 22.17

76.7 ± 22.20

0.548

 Uric acid, µmol/L

374.78 ± 90.08

328.51 ± 77.81

 < 0.001

 Albumin, g/L

41.15 ± 3.31

43.42 ± 3.13

 < 0.001

Composite parameters

 UAR

9.19 ± 2.47

7.61 ± 1.91

 < 0.001

 MHR

0.46 ± 0.19

0.37 ± 0.16

 < 0.001

 SII

674.98 ± 332.30

571.43 ± 255.82

0.006

 SIRI

1.53 ± 0.83

1.29 ± 1.10

0.047

 AISI

340.22 ± 242.10

243.97 ± 151.97

 < 0.001

QFR Characteristics

 Target vessel, n (%)

  LAD

56(67.5)

96(55.2)

0.077

  LCX

13(15.7)

43(24.7)

0.109

  RCA

14(16.9)

35(20.1)

0.612

  DS(%)

59.04 ± 12.97

29.72 ± 10.61

 < 0.001

  AS(%)

81.37 ± 11.89

49.46 ± 14.70

 < 0.001

  Microcirculatory Resistance, mmHg*s/m

146.14 ± 72.14

259.79 ± 53.21

 < 0.001